Suppr超能文献

嗜铬细胞瘤/副神经节瘤:遗传学、生物化学、免疫组织化学、代谢组学、影像学及治疗选择的最新进展

Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options.

作者信息

Antonio Karren, Valdez Ma Margarita Noreen, Mercado-Asis Leilani, Taïeb David, Pacak Karel

机构信息

Section on Medical Neuroendocrinology, The Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

Division of Endocrinology, University of Santo Tomas Hospital, Manila, Philippines.

出版信息

Gland Surg. 2020 Feb;9(1):105-123. doi: 10.21037/gs.2019.10.25.

Abstract

Pheochromocytomas and paragangliomas (PPGLs), rare chromaffin/neural crest cell tumors, are commonly benign in their clinical presentation. However, there are a number of cases presenting as metastatic and their diagnosis and management becomes a dilemma because of their rarity. PPGLs are constantly evolving entities in the field of endocrinology brought about by endless research and discoveries, especially in genetics. Throughout the years, our knowledge and perception of these tumors and their genetic background has greatly expanded and changed, and each new discovery leads to advancement in the diagnosis, treatment and follow-up of PPGLs. In this review, we discuss the recent updates in the genetics, biochemistry, immunohistochemistry, metabolomics, imaging and treatment options of PPGLs.

摘要

嗜铬细胞瘤和副神经节瘤(PPGLs)是罕见的嗜铬/神经嵴细胞瘤,临床表现通常为良性。然而,有许多病例表现为转移性,由于其罕见性,其诊断和治疗成为一个难题。PPGLs是内分泌学领域不断演变的实体,这是由无尽的研究和发现带来的,尤其是在遗传学方面。多年来,我们对这些肿瘤及其遗传背景的认识和理解有了极大的扩展和改变,每一项新发现都推动了PPGLs诊断、治疗和随访的进步。在本综述中,我们讨论了PPGLs在遗传学、生物化学、免疫组织化学、代谢组学、影像学和治疗选择方面的最新进展。

相似文献

3
Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging.
Front Endocrinol (Lausanne). 2018 Nov 27;9:515. doi: 10.3389/fendo.2018.00515. eCollection 2018.
5
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives.
Endocr Rev. 2024 Jul 12;45(4):521-552. doi: 10.1210/endrev/bnae005.
7
Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
PLoS One. 2016 Dec 16;11(12):e0168413. doi: 10.1371/journal.pone.0168413. eCollection 2016.
8
New insights on the pathogenesis of paraganglioma and pheochromocytoma.
F1000Res. 2018 Sep 20;7. doi: 10.12688/f1000research.14568.1. eCollection 2018.
9
Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance.
Cancers (Basel). 2022 Feb 12;14(4):917. doi: 10.3390/cancers14040917.
10
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
Trends Endocrinol Metab. 2017 Nov;28(11):807-817. doi: 10.1016/j.tem.2017.08.001. Epub 2017 Aug 31.

引用本文的文献

1
Somatostatin Receptor 2 Negative Pheochromocytoma Masked by Normal Adrenal Gland on Gallium-68 DOTATATE.
AACE Clin Case Rep. 2024 Dec 28;11(2):134-137. doi: 10.1016/j.aace.2024.12.011. eCollection 2025 Mar-Apr.
2
3
Pheochromocytomas and Paragangliomas-Current Management.
Cancers (Basel). 2025 Mar 19;17(6):1029. doi: 10.3390/cancers17061029.
5
Adrenal epinephrine facilitates erythropoietin gene activation by hypoxia through β2 adrenergic receptor interaction with Hif-2α.
Am J Physiol Regul Integr Comp Physiol. 2025 Jan 1;328(1):R75-R80. doi: 10.1152/ajpregu.00201.2024. Epub 2024 Nov 25.
6
Unrecognised paraganglioma of the urinary bladder precipitating hypertensive crisis.
BMJ Case Rep. 2024 Apr 29;17(4):e259283. doi: 10.1136/bcr-2023-259283.
7
Detection and Surgical Approach to Pheochromocytoma: A Case Report.
Cureus. 2024 Mar 4;16(3):e55504. doi: 10.7759/cureus.55504. eCollection 2024 Mar.
8
Paraganglioma at the cerebellopontine angle: A case report and review of literature.
Clin Case Rep. 2024 Mar 4;12(3):e8584. doi: 10.1002/ccr3.8584. eCollection 2024 Mar.
9
Bilateral Pheochromocytoma and Paraganglioma Tumors Due to Von Hippel-Lindau Syndrome in a 15-Year-Old Boy: A Case Report.
Cureus. 2023 Oct 27;15(10):e47787. doi: 10.7759/cureus.47787. eCollection 2023 Oct.
10
Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience.
Endocr Oncol. 2023 May 10;3(1):e220091. doi: 10.1530/EO-22-0091. eCollection 2023 Jan 1.

本文引用的文献

1
Pheochromocytoma and Paraganglioma.
N Engl J Med. 2019 Aug 8;381(6):552-565. doi: 10.1056/NEJMra1806651.
3
Current experts' views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma.
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2223-2224. doi: 10.1007/s00259-019-04435-z. Epub 2019 Jul 22.
4
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with Lu-DOTATATE.
Cancers (Basel). 2019 Jun 28;11(7):909. doi: 10.3390/cancers11070909.
7
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Am J Hum Genet. 2019 May 2;104(5):1008-1010. doi: 10.1016/j.ajhg.2019.04.010.
8
A Previously Unrecognized Monocytic Component of Pheochromocytoma and Paraganglioma.
Endocr Pathol. 2019 Jun;30(2):90-95. doi: 10.1007/s12022-019-9575-6.
9
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies.
Cancers (Basel). 2019 Mar 28;11(4):436. doi: 10.3390/cancers11040436.
10
Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
Horm Metab Res. 2019 Jul;51(7):451-457. doi: 10.1055/a-0851-3275. Epub 2019 Mar 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验